Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Square Brussels Convention Centre

Mar 12, 2024 9:00 AM - Mar 14, 2024 4:00 PM

Glass Entrance, Mont des Arts/Kunstberg, 1000 Brussels, Belgium

DIA Europe 2024

HTA Townhall – Ready for 2025 EU Joint Clinical Assessment

Session Chair(s)

Representative Invited

Representative Invited

European Medicines Agency

Niklas  Hedberg, MPharm

Niklas Hedberg, MPharm

HTACG Co-Chair & Chief Pharmacist

Dental and Pharmaceutical Benefits Agency, TLV, Sweden

The EU HTA Regulation will change the HTA decision making landscape in EU and preparation is in full speed by all stakeholders. This session will address this and other hot topics in the HTA arena. As the EU HTA Joint Clinical Assessment (JCA) will parallel the review process by Regulators, time for preparation of both dossiers, review, decision making and alignment with subsequent national reimbursement processes will provide new challenges for industry, HTA bodies and Regulatory Agencies. Patients and Physicians expect that access in innovation will be facilitated. This session will outline the challenges from various stakeholder perspectives and provide a vision on how all can best interact during the procedure while keeping the remit of the various assessment bodies. As an outcome we expect recommendations - what gaps still need to be closed on our way to full implementation. Several implementing acts are still in drafting stage.

Learning Objective : This session will provide an overview on the challenges for applicants, Regulators and HTAs in implementing the HTA regulation into practice. It will explain how companies can prepare themselves. It will predict how all stakeholders can best interact during the procedure.

Speaker(s)

Paul  De Boissieu

Panelist

Paul De Boissieu

HAS, France

Scientific Project Manager

Niklas  Hedberg, MPharm

Panelist

Niklas Hedberg, MPharm

Dental and Pharmaceutical Benefits Agency, TLV, Sweden

HTACG Co-Chair & Chief Pharmacist

Valentina  Strammiello, MA

Panelist

Valentina Strammiello, MA

European Patients' Forum, Belgium

Director of Programmes

Isabelle  Stoeckert, PharmD, PMP

Panelist

Isabelle Stoeckert, PharmD, PMP

Bayer, Germany

VP. Head Regulatory Affairs Europe Middle East Africa,

Maya  Matthews

Panelist

Maya Matthews

European Commission , Belgium

Head of Unit State of Health, European Semester, Health Technology Assessment

Inka  Heikkinen, MBA, MS, MSc

Panelist

Inka Heikkinen, MBA, MS, MSc

Lundbeck, Denmark

Regulatory Policy Lead

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.